DCOY (Decoy Therapeutics Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Decoy Therapeutics Inc. Common Stock (DCOY) is a publicly traded the market company. As of May 21, 2026, DCOY trades at $5.56 with a market cap of $2.47M and a P/E ratio of 0.00. DCOY moved +3.49% today. Year to date, DCOY is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $4.32 to $16.92. Rallies surfaces DCOY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns DCOY stock?

Rallies tracks hedge fund and 13F ownership for DCOY, including fund holders, share counts, and position changes when data is available.

DCOY Key Metrics

Key financial metrics for DCOY
MetricValue
Price$5.56
Market Cap$2.47M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$16.92
52-Week Low$4.32
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest DCOY News

DCOY Analyst Consensus

DCOY analyst coverage data. Average price target: $0.00.

Common questions about DCOY

Who owns DCOY stock?
Rallies tracks hedge fund and 13F ownership for DCOY, including fund holders, share counts, and position changes when data is available.
Does Rallies show 13F holders for DCOY?
Yes. Rallies tracks hedge fund and 13F ownership data for DCOY, including fund names, share counts, latest tracked quarter, and position changes when available.
Is DCOY research on Rallies investment advice?
No. Rallies provides research, data, and educational context for DCOY. It does not provide personalized investment advice.
DCOY

DCOY